Nonviolent Self-Catabolic DNAzyme Nanosponges for Smart Anticancer Drug Delivery

Abstract

The development of self-assembled DNA nanomedicine requires a facile and accurate DNA degradation strategy for precisely programmable drug release. Conventional DNA catabolic strategies are restrained with the fragile and unclear enzymatic reactions that might lead to inefficient and uncontrollable digestion of DNA scaffolds and thus might bring undesirable side effects to the sophisticated biosystems. Herein we reported a versatile selfsufficient DNAzyme-driven drug delivery system consisting of the rolling circle polymerized DNAzyme−substrate scaffolds and the encapsulated pH-responsive ZnO nanoparticles (NPs). The full DNAzyme nanosponges (NSs) were also encoded with multivalent tandem aptamer sequences to facilitate their efficient delivery into cancer cells, where the acidic endo/lysosomal microenvironment stimulates the dissolution of ZnO into Zn 2+ ions as DNAzyme cofactors and therapeutic reactive oxygen species generators. The supplement Zn 2+ cofactors mediated the nonviolent DNAzyme-catalyzed cleavage of DNA scaffolds for precise and efficient drug administrations with synergistically enhanced therapeutic performance. The facile design of DNAzyme, together with their cost-effective and intrinsic robust features, is anticipated to provide extensive insights for the development of DNA-based therapeutic platforms by activating the specific intracellular biocatalytic reactions. As an intelligent and nonviolent self-driven drug delivery platform, the present DNAzyme NS system could be engineered with more therapeutic sequences and agents and was anticipated to show exceptional promise and versatility for applications in biomedicine and bioengineering.

Silver‐Laden Black Phosphorus Nanosheets for an Efficient In Vivo Antimicrobial Application

“…The intrinsic susceptibility of antibacterial BPNs and AgNPs was assessed by using the combination index (CI) via the Chou–Talalay method. [ 36 ] The CI value is the quantitative representation of a drug combination and defined as additive (CI = 1), synergistic (CI < 1), and antagonistic effects (CI > 1), respectively. The lower CI value reveals a stronger synergy.…”

A DNA–Azobenzene Nanopump Fueled by Upconversion Luminescence for Controllable Intracellular Drug Release

“…To overcome this drawback, this work used azo‐functionalized DNA strands to design a nanopump for efficient and controllable drug release. Flexible DNA chains could be compactly assembled on UCNPs to act as the pump‐type switcher triggered by the reversible conformational change of azo, which is conveniently fueled by Vis and UV irradiation emitted from the UCNPs. Moreover, the anticancer drug doxorubicin (DOX) could be selectively intercalated in a specific DNA helix for highly efficient loading (Scheme a).…”

Circular Nucleic Acids: Discovery, Functions and Applications

“…Wang et al. developed a DNAzyme‐driven drug delivery system, which consists of targeting aptamers, self‐degraded DNAzyme‐substrate scaffolds, drug molecules, and pH‐responsive ZnO nanoparticles (Figure D) . The Zn 2+ ions released due to the dissolution of ZnO at acidic endo/lysosomal microenvironment served as DNAzyme cofactors to mediate the degradation of DNA scaffolds, leading to efficient drug administrations.…”